A message from RxFunction regarding COVID-19.
In The News
RxFunction Adds VP of Business Development
Johns Hopkins School of Medicine, Baltimore, Maryland added as 5th walk2Wellness Clinical Study Site
Lars Oddsson to Present March 6th at ISPRM 2020
walk2Wellness Clinical Data Presented at ACRM 2019
RxFunction Expands IP with Patent Issued August 2019
Fourth Study Site Added to walk2Wellness Clinical Trial
Walkasins® clinical research published April 30, 2019 in PLOS ONE. Shows short-term use of device lowers fall-risk for peripheral neuropathy patients.
RxFunction Expands Sales Team
Study Update Presented at Peripheral Nerve Society
RxFunction™ Announces Walkasins® Market Launch
Next Page »
© 2020 RxFunction, Inc.